BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anti-Cancer Drugs 2004;15:439-52. [DOI: 10.1097/01.cad.0000131140.12228.bb] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Demeria D, Birchall I, Bain VG. Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy. Can J Gastroenterol 2007;21:517-8. [PMID: 17703252 DOI: 10.1155/2007/128792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Bala MM, Riemsma RP, Wolff R, Kleijnen J, Bala MM. Cryotherapy for liver metastases. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd009058] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bala MM, Riemsma RP, Wolff R, Kleijnen J; Cochrane Hepato-Biliary Group. Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastases. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010588] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Yang T, Zhao P, Rong Z, Li B, Xue H, You J, He C, Li W, He X, Lee RJ, Ma X, Xiang G. Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375. Theranostics 2016;6:142-54. [PMID: 26722380 DOI: 10.7150/thno.13130] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 7.5] [Reference Citation Analysis]
5 Park SS, Kim MA, Eom YW, Choi KS. Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe. Biochem Biophys Res Commun. 2007;363:1044-1049. [PMID: 17923112 DOI: 10.1016/j.bbrc.2007.09.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
6 Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol. 2009;24:806-814. [PMID: 19207681 DOI: 10.1111/j.1440-1746.2008.05728.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 7.5] [Reference Citation Analysis]
7 Riemsma RP, Bala MM, Wolff R, Kleijnen J. Electro-coagulation for liver metastases. Cochrane Database Syst Rev 2013;:CD009497. [PMID: 23728692 DOI: 10.1002/14651858.CD009497.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Riemsma RP, Bala MM, Wolff R, Kleijnen J. Percutaneous ethanol injection for liver metastases. Cochrane Database Syst Rev 2013;:CD008717. [PMID: 23728679 DOI: 10.1002/14651858.CD008717.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Lee WY, Liu KW, Yeung JH. Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells. Cancer Lett 2009;285:46-57. [PMID: 19467570 DOI: 10.1016/j.canlet.2009.04.040] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
10 Schwartz JD, Llovet JM. Molecular Targeting in Hepatocellular Carcinoma. In: Kaufman HL, Wadler S, Antman K, editors. Molecular Targeting in Oncology. Totowa: Humana Press; 2008. pp. 165-210. [DOI: 10.1007/978-1-59745-337-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Riemsma RP, Bala M, Wolff R, Kleijnen J, Riemsma RP. Percutaneous ethanol injection for liver metastases. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd008717] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Lee IJ, Chung JW, Kim HC, Yin YH, So YH, Jeon UB, Jae HJ, Cho BH, Park JH. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. J Vasc Interv Radiol. 2009;20:22-29. [PMID: 19026566 DOI: 10.1016/j.jvir.2008.09.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
13 Yang T, Chen Y, Zhao P, Xue H, You J, Li B, Liu Y, He C, Zhang X, Fan L, Lee RJ, Li L, Ma X, Xu C, Xiang G. Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules. Nanomedicine 2018;14:2009-21. [PMID: 29842934 DOI: 10.1016/j.nano.2018.05.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Bala MM, Riemsma RP, Wolff R, Kleijnen J. Cryotherapy for liver metastases. Cochrane Database Syst Rev 2013;:CD009058. [PMID: 23740609 DOI: 10.1002/14651858.CD009058.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. J Nucl Med 2009;50:871-7. [PMID: 19443599 DOI: 10.2967/jnumed.108.060558] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
16 Biffi R, Orsi F, Zampino MG, Chiappa A, Fazio N, De Braud F, Bonomo G, Monfardini L, Vigna PD, Luca F, Bodei L, Bartolomei M, Catalano G, Leonardi MC, Ferrari M, Andreoni B, Goldhirsch A, Paganelli G, Orecchia R. Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology. Ecancermedicalscience 2008;2:64. [PMID: 22275961 DOI: 10.3332/eCMS.2008.64] [Reference Citation Analysis]
17 Storman D, Swierz MJ, Riemsma RP, Wolff R, Mitus JW, Pedziwiatr M, Kleijnen J, Bala MM. Electrocoagulation for liver metastases. Cochrane Database Syst Rev 2021;1:CD009497. [PMID: 33507555 DOI: 10.1002/14651858.CD009497.pub3] [Reference Citation Analysis]
18 Rathore R, Safran H, Soares G, Dubel G, McNulty B, Ahn S, Iannitti D, Kennedy T. Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group study. Am J Clin Oncol. 2010;33:43-46. [PMID: 19687731 DOI: 10.1097/coc.0b013e31819d8668] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
19 Verhoef C, van Dekken H, Hofland L, Zondervan P, de Wilt J, van Marion R, de Man R, Ijzermans J, van Eijck C. Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics. Dig Surg 2008;25:21-6. [DOI: 10.1159/000117819] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
20 Chung GE, Lee JH, Kim HY, Hwang SY, Kim JS, Chung JW, Yoon JH, Lee HS, Kim YJ. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology. 2011;258:627-634. [PMID: 21273524 DOI: 10.1148/radiol.10101058] [Cited by in Crossref: 165] [Cited by in F6Publishing: 166] [Article Influence: 15.0] [Reference Citation Analysis]
21 Kern MA, Breuhahn K, Schuchmann M, Schirmacher P. [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology]. Pathologe 2007;28:261-8. [PMID: 17605064 DOI: 10.1007/s00292-007-0890-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies. World J Gastroenterol 2009; 15(47): 5924-5935 [PMID: 20014456 DOI: 10.3748/wjg.15.5924] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ding Y, Xie Q, Liu W, Pan Z, Fan X, Chen X, Li M, Zhao W, Li D, Zheng Q. Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway. Oxid Med Cell Longev 2020;2020:3237150. [PMID: 32411325 DOI: 10.1155/2020/3237150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yoo D, Kim KM, Jin Y, Shim JH, Ko G, Yoon H, Sung K, Lee J, Kang Y, Lim Y, Lee HC, Chung Y, Lee YS, Suh DJ. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?: Efficacy of TACE in HCC with metastasis. Journal of Gastroenterology and Hepatology 2011;26:145-54. [DOI: 10.1111/j.1440-1746.2010.06341.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
25 Park SS, Lee DM, Lim JH, Lee D, Park SJ, Kim HM, Sohn S, Yoon G, Eom YW, Jeong S, Choi EK, Choi KS. Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis. Carcinogenesis 2018;39:458-70. [DOI: 10.1093/carcin/bgy003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ikeda M, Maeda S, Ashihara H, Nagahama H, Tanaka M, Sasaki Y. Transcatheter arterial infusion chemotherapy with cisplatin–lipiodol suspension in patients with hepatocellular carcinoma. J Gastroenterol 2010;45:60-7. [DOI: 10.1007/s00535-009-0109-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
27 Bala MM, Riemsma RP, Wolff R, Kleijnen J. Microwave coagulation for liver metastases. Cochrane Database Syst Rev. 2013;10:CD010163. [PMID: 24122576 DOI: 10.1002/14651858.cd010163.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
28 Lambert B, Van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2005;32:980-989. [PMID: 16032439 DOI: 10.1007/s00259-005-1859-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
29 Samonakis DN, Notas G, Christodoulakis N, Kouroumalis EA. Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken. Dig Dis Sci. 2008;53:2359-2365. [PMID: 18273705 DOI: 10.1007/s10620-007-0175-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kobayashi S, Takahashi S, Kato Y, Gotohda N, Nakagohri T, Konishi M, Kinoshita T. Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2011;18:559-566. [PMID: 21331804 DOI: 10.1007/s00534-011-0372-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
31 Schillaci O, Filippi L, Danieli R, Simonetti G. Single-Photon Emission Computed Tomography/Computed Tomography in Abdominal Diseases. Seminars in Nuclear Medicine 2007;37:48-61. [DOI: 10.1053/j.semnuclmed.2006.07.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
32 Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Aliment Pharmacol Ther. 2009;29:1291-1298. [PMID: 19392861 DOI: 10.1111/j.1365-2036.2009.04016.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
33 Riemsma RP, Bala MM, Wolff R, Kleijnen J, Riemsma RP. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd009498.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
34 Lee WY, Cheung CC, Liu KW, Fung KP, Wong J, Lai PB, Yeung JH. Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells. J Nat Prod 2010;73:854-9. [PMID: 20455578 DOI: 10.1021/np900792p] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
35 Hu HT, Kim JH, Lee LS, Kim KA, Ko GY, Yoon HK, Sung KB, Gwon DI, Shin JH, Song HY. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol. 2011;22:917-923. [PMID: 21571545 DOI: 10.1016/j.jvir.2011.03.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
36 Nakamura M, Nagano H, Marubashi S, Miyamoto A, Takeda Y, Kobayashi S, Wada H, Noda T, Dono K, Umeshita K, Monden M. Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. Cancer 2008;112:1765-71. [PMID: 18327806 DOI: 10.1002/cncr.23356] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
37 Qian H, Yang Y, Wang X. Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy. Eur J Pharm Sci. 2011;43:125-131. [PMID: 21514382 DOI: 10.1016/j.ejps.2011.04.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
38 Bala MM, Riemsma RP, Wolff R, Pedziwiatr M, Mitus JW, Storman D, Swierz MJ, Kleijnen J. Cryotherapy for liver metastases. Cochrane Database Syst Rev 2019;7:CD009058. [PMID: 31291464 DOI: 10.1002/14651858.CD009058.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Riemsma RP, Bala MM, Wolff R, Kleijnen J. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Cochrane Database Syst Rev 2013;:CD009498. [PMID: 23633373 DOI: 10.1002/14651858.CD009498.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
40 Schwartz JD, Sung M, Schwartz M, Lehrer D, Mandeli J, Liebes L, Goldenberg A, Volm M. Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist 2005;10:718-27. [PMID: 16249352 DOI: 10.1634/theoncologist.10-9-718] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
41 McLennan G, Cressman EN, Xu Y, Zhang D, Jagtap MR, Jayaram HN. The effect of benzamide riboside on the VX2 model of liver cancer in rabbits. J Vasc Interv Radiol 2005;16:1499-504. [PMID: 16319157 DOI: 10.1097/01.RVI.0000185416.08458.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Wadler S. Thalidomide for advanced hepatocellular carcinoma: Is this a real alternative? Cancer 2005;103:1-4. [DOI: 10.1002/cncr.20731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
43 Riemsma RP, Bala MM, Wolff R, Kleijnen J, Riemsma RP. Transarterial (chemo)embolisation for liver metastases. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd009498] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]